IEFA vs. EEM: Which International ETF Is Better for Long-Term Investors?
By Maksym Misichenko · Nasdaq ·
By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panelists agreed that while IEFA offers advantages in fees and yield, EEM's concentrated tech exposure, particularly in semiconductors, presents significant risks. The panelists were divided on whether EEM's higher fees and risks are justified by its potential outperformance, with some arguing for a closing valuation gap and others warning of unaddressed risks.
Risk: EEM's high concentration in the semiconductor cycle, particularly TSMC, could lead to violent drawdowns if the AI capex cycle cools or geopolitical risks flare up.
Opportunity: EEM's high valuation multiple could compress if EM earnings accelerate, driven by a catalyst such as improved global demand, potentially offsetting its higher fees.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Both the iShares Core MSCI EAFE ETF (NYSEMKT:IEFA) and the iShares MSCI Emerging Markets ETF (NYSEMKT:EEM) offer international equity exposure, but they serve different roles in a diversified portfolio. IEFA tracks developed markets like Japan and Europe, whereas EEM focuses on developing nations such as China and South Korea. This comparison helps clarify which regional focus aligns with your strategy.
| Metric | EEM | IEFA | |---|---|---| | Issuer | iShares | iShares | | Expense ratio | 0.72% | 0.07% | | 1-yr return (as of June 12, 2026) | 45.2% | 20.9% | | Dividend yield | 1.7% | 3.3% | | Beta | 1.03 | 0.89 | | AUM | $30.3 billion | $187.4 billion |
Cost is a significant differentiator, as the iShares Core MSCI EAFE ETF is much more affordable with a 0.07% expense ratio. The iShares Core MSCI EAFE ETF also offers a higher payout for those focused on income.
| Metric | EEM | IEFA | |---|---|---| | Max drawdown (5 yr) | (39.8%) | (30.4%) | | Growth of $1,000 over 5 years (total return) | $1,374 | $1,476 |
The iShares Core MSCI EAFE ETF allocates roughly 23% to financial services, 20% to industrials, and 12% to technology. It holds about 2,600 positions, and its largest positions include ASML at 2.8%, HSBC Holdings at 1.3%, and Roche at 1.1%. Launched in 2012, the fund has a trailing-12-month dividend of $3.18 per share.
In contrast, the iShares MSCI Emerging Markets ETF is more concentrated, with 43% in technology, 18.5% in financial services, and 8% in consumer cyclical stocks. It reports more than 1,000 holdings, and its top positions include Taiwan Semiconductor Manufacturing at 14.7%, Samsung Electronics at 8.3%, and SK Hynix at 6.8%. Launched in 2003, this fund has paid $1.21 per share over the trailing 12 months.
For more guidance on ETF investing, check out the full guide at this link.
Investors looking to add international exposure to their portfolios may find themselves considering two iShares options: IEFA and EEM. IEFA provides low-cost exposure to developed international markets, while EEM focuses on emerging economies. That distinction is important. IEFA’s focus on developed countries outside of the U.S. and Canada gives you diversification with less risk, but possibly less total upside. It’s a huge fund with low fees and an attractive dividend yield, and it’s more diversified across steady industries like financial services and industrials.
EEM’s sector focus on technology is largely due to its position in Taiwan Semiconductor Manufacturing, which is headquartered in Taiwan despite trading on the U.S. stock market. Its explosive recent performance amid the artificial intelligence wave likely accounts for much of EEM’s recent returns. EEM is also a way to gain exposure to Samsung and SK Hynix, which are not directly available to retail investors in the U.S. While emerging market stocks have the potential for huge gains, they also carry greater risk in the form of currency fluctuations and political instability. EEM also has a much higher expense ratio.
Long-term investors looking to maximize their diversification may want to hold both funds, but it might be wise to allocate more investment dollars to IEFA, given its relative safety, lower fees, and higher yield. If you’re looking to capture some of the exciting gains of EEM, you could also hand-pick individual winners, like Taiwan Semi, rather than taking on the risk of 1,000 emerging markets companies.
Before you buy stock in iShares Trust - iShares Core Msci Eafe ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and iShares Trust - iShares Core Msci Eafe ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $424,531! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,273,016!
Now, it’s worth noting Stock Advisor’s total average return is 940% — a market-crushing outperformance compared to 209% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of June 17, 2026. *
HSBC Holdings is an advertising partner of Motley Fool Money. Sarah Sidlow has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends ASML and Taiwan Semiconductor Manufacturing. The Motley Fool recommends HSBC Holdings and Roche Holding AG. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Long-run EM growth potential can outpace IEFA’s price-and-income advantages, making the cost win a conditional outcome at best."
Article paints IEFA as the clear winner on fee and income, but long-horizon returns hinge on growth regimes, not expense ratios. Developed markets can stall while EM cycles re-accelerate if policy and global demand improve. Currency risk matters: a stronger dollar can blunt non-US gains even as local earnings improve. The data window (1-year return as of 2026-06-12) can be cherry-picked and ignores drawdowns, regime shifts, and dividend sustainability. A robust view requires regime-tilt thinking, valuation dispersion, and considering diversification within a single basket rather than chasing a static cost/yield delta.
If EM growth re-accelerates and policy support strengthens, EEM could outperform IEFA over a full cycle; the AI/tech rally in EM could lift EM valuations more than IEFA’s developed-market tilt.
"EEM functions less as a diversified emerging market index and more as a high-fee, concentrated semiconductor sector bet that exposes investors to unnecessary idiosyncratic risk."
The article presents a classic 'core vs. satellite' debate, but it ignores the structural decay of EEM's fee structure. Paying 72 basis points for an index-tracking ETF in 2026 is egregious when lower-cost alternatives like IEMG exist. While IEFA is the superior 'set-it-and-forget-it' vehicle for developed market exposure, the article glosses over the fact that EEM is effectively a concentrated bet on the semiconductor cycle via TSMC, Samsung, and SK Hynix. If the AI capex cycle cools, EEM’s 43% tech weight will lead to a violent drawdown that far exceeds its historical beta, rendering the 'diversification' argument moot.
If emerging market middle-class consumption growth accelerates, EEM’s concentration in tech-heavy Asian tigers might be the only way to capture that demographic alpha, making the high fee a negligible cost of entry.
"This isn't a developed-vs.-emerging-markets comparison; it's a cyclical sector bet (semiconductors) vs. diversified developed markets, and the article obscures that distinction to make IEFA look like the obvious choice."
The article presents a false choice framed as 'safety vs. upside.' IEFA's 20.9% 1-yr return vs. EEM's 45.2% isn't about IEFA being 'safer'—it's about sector timing. IEFA's 0.65% fee advantage is real but overstated as a differentiator when the 5-yr total return gap is only $102 per $1,000 invested ($1,476 vs. $1,374). The article conflates EEM's concentration risk (TSMC at 14.7%) with emerging markets risk broadly. Missing: currency headwinds on IEFA (yen, euro weakness), geopolitical China exposure in EEM that could reverse gains overnight, and whether AI-driven semiconductor outperformance is cyclical or structural. The 'hand-pick TSMC instead' suggestion ignores that EEM provides diversified EM exposure beyond semiconductors.
EEM's 45% YTD return is almost entirely TSMC/semiconductor-driven—a single-sector bet masquerading as emerging markets exposure. If chip cycle rolls over or Taiwan geopolitical risk spikes, EEM could crater 30%+ while IEFA's diversified industrial/financial base provides genuine downside protection.
"EEM's semiconductor-led upside from ongoing AI demand outweighs its higher fees and volatility for long-term total-return investors."
The article correctly flags IEFA's structural advantages in cost (0.07% vs 0.72%) and yield (3.3%), yet underplays EEM's 45.2% one-year return versus IEFA's 20.9%, driven by concentrated AI/semiconductor exposure via TSM, Samsung, and SK Hynix. Five-year max drawdowns and backward-looking volatility metrics ignore whether developed-market defensiveness will persist amid slowing European and Japanese growth. EEM's tech weighting could deliver sustained outperformance if AI capex remains elevated, offsetting higher fees and political risks for investors with multi-decade horizons.
EEM's recent outperformance may prove transitory once AI spending normalizes, leaving investors exposed to recurring EM currency and governance shocks that IEFA largely sidesteps.
"A 12-month EM outperformance driven by AI/semiconductor exposure is not durable; over 3–5 years, policy, currency, and concentration risk could cause EEM to underperform IEFA."
Grok flags EEM's tech tilt and a single-year return; the flaw is treating that as durability. A 12-month run is noise versus a 3–5 year earnings regime. EM policy risk, currency swings, and a potential AI-capex peak could unwind quickly; EEM's concentration amplifies drawdowns if TSMC/Samsung AI cycle cools or geopolitics flare, while IEFA's diversification cushions shocks. The article's window underweights regime risk and drawdown potential.
"EEM's valuation discount relative to IEFA provides a better margin of safety than the latter's defensive sector tilt."
Claude and Gemini are fixated on EEM's tech concentration, but they ignore the valuation dispersion. EEM trades at roughly 12x forward earnings, while IEFA’s heavy hitters in European financials and industrials are already pricing in a 'soft landing' that may not materialize. If European growth stagnates, IEFA’s 'defensive' nature is a trap. I’m betting on the valuation gap closing; EEM’s high fee is irrelevant if the earnings growth delta between EM and DM widens further.
"Valuation gaps persist when risk premiums are justified; EEM's discount reflects real structural risks, not mispricing."
Gemini's valuation arbitrage argument is testable but incomplete. Yes, EEM's 12x forward P/E vs. IEFA's embedded 'soft landing' pricing is real. But EEM's valuation discount reflects genuine risks: currency volatility, geopolitical Taiwan exposure, and lower institutional quality. A 4x P/E gap doesn't close without a catalyst. Where's the trigger for EM earnings acceleration that justifies re-rating? AI capex alone won't sustain it if global demand weakens. Gemini assumes mean reversion; I don't see the mechanism.
"EEM's valuation discount reflects sticky risks unlikely to resolve without a clear non-AI catalyst."
Gemini’s valuation gap thesis overlooks how EEM’s 12x multiple already embeds persistent governance and Taiwan-specific risks that Claude flagged. Those frictions rarely resolve quickly enough for mean reversion to deliver alpha net of fees and drawdowns. Without a concrete policy or demand catalyst beyond AI capex, the discount is more likely to persist than compress, leaving IEFA’s diversified base less vulnerable to sudden repricing.
The panelists agreed that while IEFA offers advantages in fees and yield, EEM's concentrated tech exposure, particularly in semiconductors, presents significant risks. The panelists were divided on whether EEM's higher fees and risks are justified by its potential outperformance, with some arguing for a closing valuation gap and others warning of unaddressed risks.
EEM's high valuation multiple could compress if EM earnings accelerate, driven by a catalyst such as improved global demand, potentially offsetting its higher fees.
EEM's high concentration in the semiconductor cycle, particularly TSMC, could lead to violent drawdowns if the AI capex cycle cools or geopolitical risks flare up.